MARIA CUADRA: Open Payments
NPI 1265680631 · GREENBELT, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,228 in 60 payments from 18 companies in 2025. Trend: 2023 $679 · 2024 $1,245 · 2025 $1,228
Food & beverage: $1,228
| Company | Payments | Amount |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 8 | $216 |
| ABBVIE INC. | 9 | $147 |
| Janssen Biotech, Inc. | 9 | $137 |
| AstraZeneca Pharmaceuticals LP | 6 | $119 |
| UCB, Inc. | 7 | $116 |
| ANI Pharmaceuticals, Inc. | 3 | $82 |
| Invivyd Inc | 3 | $63 |
| Amgen Inc. | 2 | $55 |
| Novartis Pharmaceuticals Corporation | 2 | $37 |
| GlaxoSmithKline, LLC. | 1 | $35 |
Products named: ACTHAR, TREMFYA, SAPHNELO, Bimzelx, PURIFIED CORTROPHIN GEL, SKYRIZI, PEMGARDA, RINVOQ.
Industry payments across MD — which companies pay providers there.
